跳至主要内容
临床试验/NCT01746498
NCT01746498已完成不适用

Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer Patients

Assiut University1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1
主要终点
Minimental state Examination

研究概览

简要总结

The current study is planed to compare the efficacy of real (anodal and cathodal) vs sham transcranial direct current stimulation (tDCS) applied over the left dorsolateral prefrontal cortex (DLPFC) on cognitive functions and cortical excitability of patients with Alzheimer disease (AD).

Thirty three with mild to moderate Alzheimer's disease (AD) patients (diagnosis of probable AD according to the criteria of the National Institute of Neurological and Communicative Disorders and Stroke Alzheimer Disease and Related Disorders Association [NINCDS-ADRDA] were included in this study) were randomly classified into one of three groups (eleven for each group). The first group received anodal tDCS over left DLPFC and 2rd group received cathodal tDCS on the left DLPFC and the 3rd group received sham tDCS stimulation, daily for 10 consecutive days (5 days/week for 2 weeks). Minimental State Examination (MMSE), psychometric assessment for cognitive functions (MMSE, Wechsler memory scale, Wechsler adult Intelligent scale) were assessed before, after 10th sessions, and then after 1 and 2 month. Cortical excitability was assessed in both hemispheres before and after the end of sessions. Neurophysiological evaluations included resting and active motor threshold (rMT and aMT), and cortical silent period (CSP).

At the time of recruitment, none of the patients taking antidepressants, or neuroleptic, sedative-hypnotic drugs for at least two weeks before the assessment. All participants or their caregivers will give informed consent before participation in the test and after full explanation of the study protocol.

Outcome: The real group received (anodal and cathodal) tDCS are expected to have more improvement on cognitive functions compared to sham tDCS group. tDCS is considered new adjuvant non pharmacological therapeutic tool for management of AD patients with mild to moderate degree dementia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Thirty patients with a diagnosis of probable AD according to the criteria of the National Institute of Neurological and Communicative Disorders Association (NINCDS-ADRDA) (McKhann G et al.,1994) will be included in this study.

排除标准

  • •previous history of stroke
  • •Metabolic disturbances
  • •Other major medical illness or epilepsy
  • •Patients metallic objects in the body
  • •Patients subjected to a craniotomy in the past.

研究组 & 干预措施

Group 1

Active Comparator

11 patients We Applied real anodal tDCS on the left dorsolateral prefrontal cortex (DLPFC)20 minutes every day for 10 consecutive days.

干预措施: Direct current stimulation using Anodal electrode (Procedure)

Group 2

Active Comparator

11 patients we applied cathodal tDCS on left DLPFC for 20 minutes every day for 10 consecutive days.

干预措施: direct current stimulation using cathodal electrode (Procedure)

Group 3

Sham Comparator

11 patients We applied sham stimulations(anodal tDCS) on the left DLPFC for few seconds the stop stimulations 2 mA every day for 10 days.

干预措施: Sham direct current stimulation (Procedure)

结局指标

主要结局

Minimental state Examination

时间窗: base line and after 2 months

To measure the cognitive function in alzheimer patients through measuring orientation, Registration, Attention and calculation, Recall,language, and copying with a total score 30.

次要结局

  • changes in cortical excitability(Base line and after 10 days)
  • Wechsler memory scale(Basal and 2 months)
  • Intelligent questant ( IQ)(basal and 2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eman M. Khedr

Professor

Assiut University

研究点 (1)

Loading locations...

相似试验